Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × copanlisib × 90 days × Clear all

Sponsor

Conditions

Lymphoma 4 Multiple Myeloma 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hematologic Neoplasms 1 HER2 Positive Breast Cancer 1 Glioma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 17 Rituximab 16 fludarabine 11 pirtobrutinib 8 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 venetoclax 5 polatuzumab vedotin 5 obinutuzumab 5 glofitamab 5 Vincristine 5 Doxorubicin 5 zanubrutinib 4 Prednisone 4 Dexamethasone 4 Biopsy 4 tazemetostat 3 tafasitamab 3 pembrolizumab 3 fludarabine phosphate 3 acalabrutinib 3 Nivolumab 3 Leukapheresis 3 Etoposide 3 Bendamustine Hydrochloride 3 pomalidomide 2 loncastuximab tesirine 2 ibrutinib 2 etoposide phosphate 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡